Skip to main content
. 2021 Dec 10;10:50. doi: 10.1186/s40035-021-00275-w

Fig. 2.

Fig. 2

Receiver operating characteristic curves (ROC) of pGFAP, plasma neurofilament light chain, their combination, a basic model with risk factors (age, sex and APOE), and a combination of plasma biomarkers with additional risk factors to discriminate FTD from AD (a), FTD from normal cognitively normal (b), and AD from cognitively normal (c). AUC, area under the curve; pGFAP, plasma glial fibrillary acidic protein; pNfL, plasma neurofilament light chain; CN, cognitively normal participants; FTD, frontotemporal dementia; AD, Alzheimer’s disease